BridgeBio Oncology Therapeutics Inc. (BBOT) Stock Price History
Historical prices from 2024 to 2026
Loading 10-year price history...
BBOT Historical Performance
Short-Term Returns
BBOT Stock Price Trajectory (2024–2026)
As of May 8, 2026, BridgeBio Oncology Therapeutics Inc. (BBOT) trades at $7.86, representing a -27.6% return over the past year. The stock has delivered a -22.9% total return over five years (-5.1% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $14.87 on December 8, 2025. From this peak, BBOT has corrected -47.1%, currently trading 27% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers BBIO (+88.3% 1Y), KYMR (+190.7% 1Y), and TPVG (+2.0% 1Y), BBOT has underperformed the peer group average. Compare BBOT vs BBIO →
BBOT Historical Price Data (2025–2026)
Showing 30 of 563 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 8.36 | 8.38 | 7.63 | 7.86 | 373K | -5.64% |
| 2026-05-06 | 8.44 | 8.50 | 8.15 | 8.33 | 152K | +0.73% |
| 2026-05-05 | 8.51 | 8.66 | 8.15 | 8.27 | 158K | -2.25% |
| 2026-05-04 | 8.35 | 8.60 | 8.20 | 8.46 | 235K | +0.83% |
| 2026-05-01 | 8.42 | 8.50 | 8.19 | 8.39 | 155K | -0.24% |
| 2026-04-30 | 8.09 | 8.64 | 8.00 | 8.41 | 328K | +4.34% |
| 2026-04-29 | 8.68 | 8.97 | 8.05 | 8.06 | 564K | -8.41% |
| 2026-04-28 | 8.77 | 9.32 | 8.72 | 8.80 | 461K | +0.11% |
| 2026-04-27 | 8.75 | 9.22 | 8.75 | 8.79 | 523K | +0.11% |
| 2026-04-24 | 8.98 | 9.37 | 8.72 | 8.78 | 385K | -2.12% |
| 2026-04-23 | 8.80 | 9.03 | 8.64 | 8.97 | 381K | +1.13% |
| 2026-04-22 | 9.39 | 9.55 | 8.55 | 8.87 | 796K | -6.24% |
| 2026-04-21 | 9.45 | 9.68 | 9.26 | 9.46 | 904K | +2.16% |
| 2026-04-20 | 9.33 | 9.43 | 9.21 | 9.26 | 552K | -0.96% |
| 2026-04-17 | 9.36 | 9.63 | 9.23 | 9.35 | 586K | +1.41% |
| 2026-04-16 | 9.43 | 9.43 | 9.06 | 9.22 | 244K | -1.81% |
| 2026-04-15 | 9.20 | 9.52 | 9.05 | 9.39 | 522K | +2.29% |
| 2026-04-14 | 9.03 | 9.25 | 8.50 | 9.18 | 577K | +2.57% |
| 2026-04-13 | 8.69 | 9.40 | 8.50 | 8.95 | 931K | +6.55% |
| 2026-04-10 | 8.86 | 8.86 | 8.11 | 8.40 | 290K | -5.14% |
| 2026-04-09 | 8.56 | 9.06 | 8.43 | 8.86 | 348K | +2.49% |
| 2026-04-08 | 8.75 | 8.92 | 8.41 | 8.64 | 413K | +2.86% |
| 2026-04-07 | 8.86 | 8.86 | 8.08 | 8.40 | 380K | -5.72% |
| 2026-04-06 | 8.87 | 9.21 | 8.78 | 8.91 | 516K | 0.00% |
| 2026-04-02 | 8.80 | 9.09 | 8.80 | 8.91 | 157K | -1.33% |
| 2026-04-01 | 8.93 | 9.15 | 8.80 | 9.03 | 325K | +0.89% |
| 2026-03-31 | 8.84 | 9.06 | 8.79 | 8.95 | 201K | +3.11% |
| 2026-03-30 | 8.92 | 9.12 | 8.51 | 8.68 | 123K | -2.25% |
| 2026-03-27 | 9.23 | 9.36 | 8.87 | 8.88 | 142K | -3.79% |
| 2026-03-26 | 9.10 | 9.47 | 9.10 | 9.23 | 69K | -0.22% |
See BBOT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BBOT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BBOT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBBOT — Frequently Asked Questions
Quick answers to the most common questions about buying BBOT stock.
How has BBOT stock performed recently?
BBOT declined -27.6% over the past year, below its 5-year annualized CAGR of -5.1%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is BBOT's all-time high price?
BridgeBio Oncology Therapeutics Inc. reached $14.87 on 2025-12-08. The 52-week high is $14.87. Current 1-year return of -27.6% places the stock further from historical peaks.
Where can I download BBOT historical price data?
This page provides BBOT daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2024-2026, downloadable in CSV format.